Prostate Cell News Volume 11.29 | Aug 7 2020

    0
    23







    2020-08-07 | PCN 11.29


    Prostate Cell News by STEMCELL Technologies
    Vol. 11.29 – 7 August, 2020
    TOP STORY

    Mitochondrial Functional and Structural Impairment Is Involved in the Antitumor Activity of δ-Tocotrienol in Prostate Cancer Cells

    The authors investigated whether δ-tocotrienol (δ-TT) might exert its activity by impairing mitochondrial functions. They demonstrated that, in PC3 and DU145 cells, δ-TT impaired mitochondrial respiration and structural dynamics.
    [Free Radical Biology and Medicine]

    AbstractGraphical Abstract

    Explore tools and resources for your return to the lab
    PUBLICATIONSRanked by the impact factor of the journal

    Quercetin–Resveratrol Combination for Prostate Cancer Management in TRAMP Mice

    Scientists determined the effects of grape antioxidants quercetin and/or resveratrol against prostate cancer in the transgenic adenocarcinoma of mouse prostate (TRAMP)-model in prevention and intervention settings.
    [Cancers]

    Full Article

    Combination Therapy with Androgen Receptor N‐Terminal Domain Antagonist EPI‐7170 and Enzalutamide Yields Synergistic Activity in AR‐V7‐Positive Prostate Cancer

    Researchers evaluated the antitumor effect of a next‐generation analog of ralaniten as a monotherapy or in combination with enzalutamide in prostate cancer cells that express AR‐V7 that were resistant to enzalutamide.
    [Molecular Oncology]

    Abstract

    Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells

    Scientists developed curcumin nanoparticles and evaluated their cytotoxicity in docetaxel (DTX)-resistant castration-resistant prostate cancer (CRPC) cells for the treatment of DTX-resistant CRPC.
    [Biomedicines]

    Full Article

    The Prostaglandin Synthases, COX-2 and L-PGDS, Mediate Prostate Hyperplasia Induced by Low-Dose Bisphenol A

    In vitro studies showed that low-dose bisphenol A promoted the proliferation of human prostate fibroblasts and epithelial cells, and significantly upregulated the expression of cyclooxygenase-2 (COX-2) and lipocalin-type prostaglandin D synthase (L-PGDS) in the cells.
    [Scientific Reports]

    Full Article

    Cytoprotective Autophagy Induction by Withaferin A in Prostate Cancer Cells Involves GABARAPL1

    Researchers confirmed autophagy induction by withaferin A (WA) treatment by transmission electron microscopy using three prostate cancer cell lines. Fourteen common genes altered by 8‐ and 16‐hour exposure to WA were identified from human autophagy PCR array and these results were consistent with the RNA‐seq data.
    [Molecular Carcinogenesis]

    Abstract

    Predicting New Drug Indications for Prostate Cancer: The Integration of an In Silico Proteochemometric Network Pharmacology Platform with Patient‐Derived Primary Prostate Cells

    Investigators integrated a computational proteochemometric systems network pharmacology platform, DrugGenEx‐Net, with primary, continuous cultures of conditionally reprogrammed normal and prostate cancer (PCa) cells derived from treatment‐naive patients with primary PCa.
    [Prostate]

    Full Article

    The Spectrum of Design Solutions for Improving the Activity-Selectivity Product of Peptide Antibiotics against Multidrug-Resistant Bacteria and Prostate Cancer PC-3 Cells

    Scientists hypothesized that designed peptides with a wide spectrum of selective antimicrobial activity would also have anticancer activity, and tested this hypothesis with newly designed peptides.
    [Molecules]

    Full Article

    Chelerythrine Suppresses Proliferation and Metastasis of Human Prostate Cancer Cells via Modulating MMP/TIMP/NF-κB System

    The addition of chelerythrine significantly inhibited the proliferation of androgen-independent prostate cancer DU145 and PC-3 cells at the concentration of 5 and 10 μM, but not on androgen-dependent prostate cancer LNCaP cells as well as normal prostate epithelial cell line PrEC cells.
    [Molecular and Cellular Biochemistry]

    Abstract

    Request a free copy of the Growing Organoids from Stem Cells Wallchart
    REVIEWS

    Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review

    Researchers review the current status of immunotherapy, including new discoveries and precision approaches to prostate cancer, and discuss future directions in the continuously evolving landscape of immunotherapy.
    [International Journal of Molecular Sciences]

    Full Article

    INDUSTRY AND POLICY NEWS

    NIH Grants $1.44M to Cancer Targeted Technology to Support the Ongoing Prostate Cancer Clinical Trial of a Promising New Radiotherapeutic, CTT1403

    Cancer Targeted Technology (CTT) announced that the NIH awarded CTT $1.44M on the second year of a competitive Small Business Innovation Research Phase IIB grant.
    [Cancer Targeted Technology (Business Wire, Inc.)]

    Press Release

    ORIC Pharmaceuticals Expands Precision Oncology Pipeline with Exclusive Worldwide License to Highly Selective Allosteric PRC2 Inhibitors from Mirati Therapeutics

    ORIC Pharmaceuticals, Inc. announced it has entered into an exclusive worldwide license agreement with Mirati Therapeutics, Inc. ORIC will have exclusive worldwide rights for the development activities and commercialization of a small molecule allosteric inhibitor program directed towards the polycomb repressive complex 2, a validated oncogenic target across several cancers with promising therapeutic potential in prostate cancer, among other indications.
    [ORIC Pharmaceuticals, Inc.]

    Press Release

    FEATURED EVENT

    Cancer Stem Cells: Advances in Biology and Clinical Translation

    May 18 – May 21, 2021
    Hannover, Germany

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral and Technician Position – Molecular Mechanism of Cancer

    Rutgers Cancer Institute of New Jersey – Rutgers, New Jersey, United States

    Data Manager – Pan-Prostate Cancer Group

    European Molecular Biology Laboratory – Hinxton, Cambridge, United Kingdom

    Postdoctoral Fellow – Prostate Cancer Biology

    University of Maryland, Baltimore – Baltimore, Maryland, United States

    Postdoctoral Positions – Cancer Epigenomics

    West Virginia University – Morgantown, West Virginia, United States

    Postdoctoral Positions – Cancer Genomics/Computational Biology

    Stanford Institute for Stem Cell Biology and Regenerative Medicine – Stanford, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter